101 related articles for article (PubMed ID: 7672233)
1. Iron, desferrioxamine, and ATP interactions in proliferating lymphocytes and B-cell lines.
Latunde-Dada GO; Young SP
Biochem Soc Trans; 1995 May; 23(2):213S. PubMed ID: 7672233
[No Abstract] [Full Text] [Related]
2. Role of iron-ATP complex in lymphocyte proliferation and infiltration.
Anghileri LJ; Ortal EM; Thouvenot P
Biol Trace Elem Res; 2005; 108(1-3):69-75. PubMed ID: 16327061
[TBL] [Abstract][Full Text] [Related]
3. Synergism between iron chelators and complement for bactericidal activity.
Rivier D; Page N; Isliker H
Ann Immunol (Paris); 1983; 134C(1):25-30. PubMed ID: 6344748
[TBL] [Abstract][Full Text] [Related]
4. Effect of an iron-chelating agent on lymphocyte proliferation.
Bowern N; Ramshaw IA; Badenoch-Jones P; Doherty PC
Aust J Exp Biol Med Sci; 1984 Dec; 62 ( Pt 6)():743-54. PubMed ID: 6241825
[TBL] [Abstract][Full Text] [Related]
5. Iron chelators induce apoptosis in proliferating cells.
Hileti D; Panayiotidis P; Hoffbrand AV
Br J Haematol; 1995 Jan; 89(1):181-7. PubMed ID: 7833261
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth of the lymphocyte lines by deferoxamine under various iron-supply conditions.
Kovár J; Seligman P; Gelfand EW
Folia Biol (Praha); 1993; 39(1):29-39. PubMed ID: 8348983
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of in vitro lymphoproliferation by three novel iron chelators of the pyridoxal and salicyl aldehyde hydrazone classes.
van Reyk D; Sarel S; Hunt N
Biochem Pharmacol; 2000 Aug; 60(4):581-7. PubMed ID: 10874133
[TBL] [Abstract][Full Text] [Related]
8. Effect of ferrioxamine on the growth of Rhizopus.
Verdonck AK; Boelaert JR; Gordts BZ; Van Landuyt HW
Mycoses; 1993; 36(1-2):9-12. PubMed ID: 8316265
[TBL] [Abstract][Full Text] [Related]
9. Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and alpha-synuclein translocation in SK-N-SH cells in culture.
Sangchot P; Sharma S; Chetsawang B; Porter J; Govitrapong P; Ebadi M
Dev Neurosci; 2002; 24(2-3):143-53. PubMed ID: 12401952
[TBL] [Abstract][Full Text] [Related]
10. The influence of iron loading and iron chelation on the proliferation and telomerase activity of human peripheral blood mononuclear cells.
Bagherpour B; Gharagozloo M; Moayedi B
Iran J Immunol; 2009 Mar; 6(1):33-9. PubMed ID: 19293476
[TBL] [Abstract][Full Text] [Related]
11. Iron and deferoxamine in lymphocyte blastogenesis.
Lipsky JJ; Lietman PS
J Immunopharmacol; 1980; 2(2):179-87. PubMed ID: 6821550
[TBL] [Abstract][Full Text] [Related]
12. Prooxidant activity of ferrioxamine in isolated rat hepatocytes and linoleic acid micelles.
Bergamini S; Rota C; Staffieri M; Tomasi A; Iannone A
Chem Res Toxicol; 1999 Apr; 12(4):365-70. PubMed ID: 10207126
[TBL] [Abstract][Full Text] [Related]
13. Effect of orally active hydroxypyridinone iron chelators on human lymphocyte function.
Pattanapanyasat K; Webster HK; Tongtawe P; Kongcharoen P; Hider RC
Br J Haematol; 1992 Sep; 82(1):13-9. PubMed ID: 1419787
[TBL] [Abstract][Full Text] [Related]
14. Cellular responses to iron and iron compounds.
Brock JH; Djeha A; Ismail M; Oria R; Sinclair RH
Adv Exp Med Biol; 1994; 356():91-100. PubMed ID: 7887249
[No Abstract] [Full Text] [Related]
15. Inhibition of iron overload toxicity in rat hepatocyte cultures by pyoverdin Pf, the siderophore of Pseudomonas fluorescens.
Jego P; Hubert N; Morel I; Pasdeloup N; Ocaktan A; Abdallah M; Brissot P; Lescoat G
Biochem Pharmacol; 1992 Mar; 43(6):1275-80. PubMed ID: 1562281
[TBL] [Abstract][Full Text] [Related]
16. Iron-mediated stability of PAI-1 mRNA in adenocarcinoma cells-involvement of a mRNA-binding nuclear protein.
Radha KS; Sugiki M; Yoshida E; Harish Kumar M; Omura S; Maruyama M
Thromb Res; 2005; 116(3):255-63. PubMed ID: 15935835
[TBL] [Abstract][Full Text] [Related]
17. Malaria pigment and extracellular iron. Possible target for iron chelating agents.
van Zyl RL; Havlik I; Hempelmann E; MacPhail AP; McNamara L
Biochem Pharmacol; 1993 Apr; 45(7):1431-6. PubMed ID: 8471067
[TBL] [Abstract][Full Text] [Related]
18. Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation.
Lederman HM; Cohen A; Lee JW; Freedman MH; Gelfand EW
Blood; 1984 Sep; 64(3):748-53. PubMed ID: 6380622
[TBL] [Abstract][Full Text] [Related]
19. Uptake and intracellular handling of iron from transferrin and iron chelates by mitogen stimulated mouse lymphocytes.
Djeha A; Brock JH
Biochim Biophys Acta; 1992 Jan; 1133(2):147-52. PubMed ID: 1731957
[TBL] [Abstract][Full Text] [Related]
20. The effect of desferrithiocin, an oral iron chelator, on T-cell function.
Bierer BE; Nathan DG
Blood; 1990 Nov; 76(10):2052-9. PubMed ID: 2242426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
